ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes
Wednesday May 27, 2020
Wednesday May 27, 2020
We chat with Dr. Lisa Deal, Director of Pharmacy, Sun Behavioral Health Delaware in Georgetown, Delaware, about the unique aspects of managing mental health disorders during the COVID-19 pandemic. Considerations for both patient and clinician mental health will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday May 22, 2020
Friday May 22, 2020
Today on ASHPOfficial, we chat with student leaders across the nation about their perspectives on the COVID-19 pandemic. In this podcast, we will dive into how students are adapting to the virtual learning model and how student societies are coping with the changing environment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday May 21, 2020
Thursday May 21, 2020
Remdesivir has been added to the FDA Emergency Use Authorization list for the treatment of hospitalized patients with severe COVID-19 disease. As such, pharmacists may have questions about the practical and operational aspects of the procurement and utilization of this medication. This podcast focuses on investigational drug services, dose conservation, and clinical experiences with remdesivir. In order to learn more about early information on the clinical use of and access to Remdesivir for the treatment of patients with COVID-19, please see the full webinar recording at ASHP elearning.org.
*Recorded on 5/13
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday May 20, 2020
Wednesday May 20, 2020
Jillanne Schulte Wall, ASHP Senior Director, Health & Regulatory Policy and Mary Ann Kliethermes, ASHP Director, Medication Safety & Quality, discuss CMS’s recent telehealth changes, the resulting regulatory flexibilities that are helpful to our members and their patients, and ASHP’s next steps on telehealth advocacy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday May 18, 2020
Monday May 18, 2020
ASHP sits down with Dr. Jill Starykowicz, PharmD, BCCCP, Clinical Pharmacy Specialist, Medical/ Cardiac Intensive Care Unit and Director, PGY2 Critical Care Pharmacy Residency at Advocate Lutheran General Hospital in Park Ridge, Illinois as she discusses cytokine storm in critically ill COVID-19 patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
Friday May 15, 2020
Friday May 15, 2020
We chat with Michael Gulseth about the unique aspects of treating COVID-19 patients that present with coagulopathies. Assessing risk of thromboembolism and anticoagulation strategies in these patients will also be discussed.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday May 14, 2020
Thursday May 14, 2020
Anticoagulants are moving to the frontline in some patients with COVID-19 as emerging data shows pro-thrombotic complications occurring. Many of these agents are weight based and require lab monitoring for efficacy and safety. Unfortunately, obesity is an ongoing epidemic in the US as well and potentially worse outcomes in those with COVID-19. It is imperative that pharmacists have an understanding on how the pharmacokinetics can be altered in patients that are obese or large body weight, along with the recommended dosing weight to use.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday May 13, 2020
Wednesday May 13, 2020
While it is not uncommon to occasionally have adult-sized patients in children’s hospitals, some are preparing to support the care of more adult patients in the event of COVID-19 surge in their region. This means that pharmacists who traditionally only care pediatric patients will be caring for adult patients without conditions that are associated with pediatrics diseases. Our guests today are pediatric pharmacists from across the country who will share with us their experiences and plans to safely care for patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday May 12, 2020
Tuesday May 12, 2020
Due to the COVID-19 pandemic, our pharmacotherapy clinic had to rapidly create new workflows for telehealth services to allow for continued care of our patients, while minimizing their possible exposure to COVID-19. We will be discussing how we have rapidly converted our face-to-face pharmacist visits to telehealth visits to minimize patient exposure in the ambulatory care clinics, as well as, pharmacist/provider exposure to patients unnecessarily. In addition, we will discuss the types of telehealth visits provided, the roadblocks we have encountered/lessons learned and current reimbursement for such services.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday May 12, 2020
Tuesday May 12, 2020
CAR-T cell therapies have the potential to transform cancer treatment. Their unique toxicities require rapid recognition and specialized treatment. Collaboration between multiple disciplines is needed for the optimal management of patients undergoing CAR-T cell therapy. The purpose of this podcast is to discuss key issues that non-oncology practitioners in acute care settings will need to be familiar with to appropriately treat patients whom underwent CAR-T cell treatment and are experiencing adverse effects related to treatment.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.